AHR and cystic fibrosis: This review aims to thoroughly explore the molecular pathophysiology and current clinical treatment landscape of CF, with a particular focus on research advances regarding indole compounds and the AHR pathway in regulating immune-inflammatory responses, defending against pathogen infections, and maintaining the integrity of intestinal and pulmonary barriers.